← Back to Search

Action Observation + Mental Imagery for Muscle Wasting (STILL Trial)

N/A
Waitlist Available
Led By Matt S Stock, PhD
Research Sponsored by University of Central Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one week
Awards & highlights

STILL Trial Summary

This study is evaluating whether a week of knee-joint immobilization leads to muscle atrophy, weakness, and loss of neuromuscular function.

Eligible Conditions
  • Muscle Wasting
  • Muscle Weakness
  • Muscle Atrophy
  • Knee Injuries

STILL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Corticospinal responses
Motor unit behavior
Muscular size
+3 more
Secondary outcome measures
Compliance
Physical activity (Step count)

STILL Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ImmobilizationExperimental Treatment2 Interventions
Participants in the immobilization groups will undergo one week of unilateral knee joint immobilization of the left leg.
Group II: ControlActive Control1 Intervention
The control group will not undergo any intervention.

Find a Location

Who is running the clinical trial?

University of Central FloridaLead Sponsor
79 Previous Clinical Trials
1,098,326 Total Patients Enrolled
Matt S Stock, PhDPrincipal InvestigatorUniversity of Central Florida

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~14 spots leftby Apr 2025